Issues

Vol. 5 (No. 1) 2023 September

  1. Artificial intelligence and pharmacologists: threat or opportunity?

    F. Visioli
    Editorial, 2-4
    doi: 10.36118/pharmadvances.2023.54
    Full text PDF

  2. The use of biological and biosimilar drugs in Rheumatology and Dermatology: analysis of two prescribing centers in Sicily from 2019 to 2020

    V. Drago 1, C. B. M. Platania 2, M. A. D’Agata 3, M. A. Sortino 2
    Research Article, 5-14
    doi: 10.36118/pharmadvances.2023.51
    Full text PDF

  3. The beneficial effects of pomegranate (Punica granatum L.) consumption on human health: a review

    A. Di Napoli 1,2, F. Germani 1, F. Parisi 2, P. Zucchetti 1
    Review, 15-28
    doi: 10.36118/pharmadvances.2022.45
    Full text PDF

  4. From preclinical to clinical evidence: exploring the multiple perspectives and healing power of Boswellia serrata Roxb. ex Colebr

    M. Biagi1, G. Rigillo2, M. Sarill3, D. Collotta4, S. Di Giacomo5, 6, A. Di Sotto5, M. Grilli7, C. Luceri8, L. Milella9, E. Sangiovanni10, A. Vitalone5, M. Montopoli3, L. Testai11
    Review, 29-53
    doi: 10.36118/pharmadvances.2023.53
    Full text PDF
©2024 Edra S.p.A. - P.Iva 08056040960